Securities code: 300404 securities abbreviation: Boji Medical Technology Co.Ltd(300404) Announcement No.: 2022-003 Boji Medical Technology Co.Ltd(300404)
Annual performance forecast for 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Expected performance of the current period
1. Performance forecast period: January 1, 2021 to December 31, 2021
2. Expected performance: losses turn into profits ■ increase in the same direction and decrease in the same direction, which is basically the same
The current reporting period of the project is the same period of last year
Profit attributable to shareholders of listed companies: 37 million yuan – 48 million yuan
Net profit: 16.9886 million yuan, an increase of 117.79% – 182.54% over the same period of last year
Profit after deducting non recurring profit and loss: 23 million yuan – 34 million yuan
Net profit: 9.8555 million yuan, an increase of 133.37% – 244.99% over the same period of last year
2、 Communication with accounting firms
The financial data related to this performance forecast has not been pre communicated with the accounting firm and has not been pre audited by the accounting firm.
3、 Explanation of performance change reasons
1. The main reasons for the change of the company’s performance in 2021 are as follows:
In 2021, the company’s research projects were steadily promoted, and the company’s main business income increased compared with the same period of the previous year, resulting in an increase in the net profit attributable to the shareholders of the listed company in 2021 compared with the same period of the previous year.
2. In 2021, the company expects that the impact of non recurring profits and losses on the net profit attributable to the shareholders of the listed company will be about 10 million yuan – 16 million yuan.
4、 Risk tips
The company has no major uncertain factors affecting the accuracy of the performance forecast. 5、 Other relevant notes 1. This performance forecast is the preliminary calculation result of the company’s financial department and has not been audited by the audit institution. 2. The specific financial data of the company’s 2021 annual performance will be disclosed in detail in the company’s 2021 annual report. Please make careful decisions and pay attention to investment risks. It is hereby announced.
Boji Medical Technology Co.Ltd(300404) board of directors January 24, 2022
